Kamada (KMDA) Cash from Operations (2012 - 2026)

Kamada (KMDA) posted quarterly Cash from Operations of 291000.0 for Q1 2026, up 43.27% year-on-year from 203106.12 in Q1 2025, and down 103.85% on a QoQ basis from 7566000.0 in Q4 2025.

Kamada (KMDA) Cash from Operations (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Cash from Operations for 15 consecutive years, with 291000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Operations rose 43.27% year-over-year to 291000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25712000.0 (down 44.18% YoY) and the FY2025 annual result came in at 25490000.0, down 46.44% from the prior year.
  • Cash from Operations eased to 291000.0 in Q1 2026 per KMDA's latest filing, from 7566000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for KMDA reached as high as 22213000.0 in Q3 2024 and fell as low as 513000.0 in Q1 2025.
  • A 5-year average of 5764904.88 and a median of 5465000.0 in 2022 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2023 — Cash from Operations soared 90525.93% — and 2025, when it plunged 150.29%.
  • Year by year, Cash from Operations stood at 6742.0 in 2022, then surged by 90525.93% to 6110000.0 in 2023, then soared by 70.18% to 10398000.0 in 2024, then fell by 27.24% to 7566000.0 in 2025, then tumbled by 103.85% to 291000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered 291000.0, 7566000.0, and 10416000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -291,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -291,000.00
Mar 31, 2026 -291,000.00
Dec 31, 2025 7.57 Mn
Dec 31, 2025 7.57 Mn
Sep 30, 2025 10.42 Mn
Sep 30, 2025 10.42 Mn
Jun 30, 2025 8.02 Mn
Jun 30, 2025 8.02 Mn
Mar 31, 2025 -513,000.00
Mar 31, 2025 -513,000.00
Dec 31, 2024 10.40 Mn
Dec 31, 2024 10.40 Mn
Sep 30, 2024 22.21 Mn
Sep 30, 2024 22.21 Mn
Jun 30, 2024 13.96 Mn
Jun 30, 2024 13.96 Mn
Mar 31, 2024 1.02 Mn
Mar 31, 2024 1.02 Mn
Dec 31, 2023 6.11 Mn
Dec 31, 2023 6.11 Mn